MedTrace Logo

Topical Capsaicin for Cyclical Vomiting

NCT03223350 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-12-15

Study results available
· View outcomes & findings →

Summary

This is a phase 2 randomized controlled trial testing the effect of topical capsaicin for the relieve of nausea and vomiting.

Conditions

  • Cyclical Vomiting

Interventions

DRUG

Capsaicin 0.1% Cream

Topical application

DRUG

Placebos

placebo cream

Sponsors & Collaborators

  • Henry Ford Health System

    lead OTHER

Principal Investigators

  • Joseph Miller, MD · Henry Ford Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-20
Primary Completion
2019-08-05
Completion
2019-08-05
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03223350 on ClinicalTrials.gov